12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Thursday's intraday session. Notable gainers included Theriva Biologics, Verrica Pharmaceuticals, and Bone Biologics, while Windtree Therapeutics, AngioDynamics, and Soligenix were among the biggest losers. AngioDynamics' decline followed the release of its Q1 earnings.
October 03, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AngioDynamics' stock declined by 17.13% to $6.34 following the release of its Q1 earnings.
The decline in stock price post-earnings release suggests that the results were below investor expectations, likely leading to short-term negative impact.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Soligenix shares decreased by 16.64% to $4.06, with a market cap of $9.2 million.
The sharp decline in share price suggests negative investor sentiment or news, likely leading to short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Windtree Therapeutics shares fell by 21.5% to $1.13, reducing its market cap to $1.8 million.
The significant decline in share price indicates negative investor sentiment or adverse news, likely leading to short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Bone Biologics' stock increased by 30.98% to $1.99, raising its market cap to $3.5 million.
The sharp rise in stock price suggests positive developments or investor sentiment, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Theriva Biologics shares surged by 33.5% to $1.66, significantly increasing its market cap to $2.2 million.
The significant price increase suggests positive investor sentiment or news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Verrica Pharmaceuticals saw a 31.53% rise in its stock price to $1.46, with a market cap of $62.2 million.
The substantial increase in share price indicates strong investor interest, suggesting potential short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80